Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis

Functional screening for compounds that promote remyelination represents a major hurdle in the development of rational therapeutics for multiple sclerosis. Screening for remyelination is problematic, as myelination requires the presence of axons. Standard methods do not resolve cell-autonomous effects and are not suited for high-throughput formats. Here we describe a binary indicant for myelination using micropillar arrays (BIMA). Engineered with conical dimensions, micropillars permit resolution of the extent and length of membrane wrapping from a single two-dimensional image. Confocal imaging acquired from the base to the tip of the pillars allows for detection of concentric wrapping observed as 'rings' of myelin. The platform is formatted in 96-well plates, amenable to semiautomated random acquisition and automated detection and quantification. Upon screening 1,000 bioactive molecules, we identified a cluster of antimuscarinic compounds that enhance oligodendrocyte differentiation and remyelination. Our findings demonstrate a new high-throughput screening platform for potential regenerative therapeutics in multiple sclerosis.

[1]  Jeffrey A. Loeb,et al.  Neuregulin-1 Type III Determines the Ensheathment Fate of Axons , 2005, Neuron.

[2]  R. Colello,et al.  Signals that initiate myelination in the developing mammalian nervous system , 1997, Molecular Neurobiology.

[3]  R. Franklin,et al.  Zebrafish myelination: a transparent model for remyelination? , 2008, Disease Models & Mechanisms.

[4]  G. Wolswijk.  Chronic Stage Multiple Sclerosis Lesions Contain a Relatively Quiescent Population of Oligodendrocyte Precursor Cells , 1998, The Journal of Neuroscience.

[5]  Michelle K. Leach,et al.  A culture system to study oligodendrocyte myelination-processes using engineered nanofibers , 2012, Nature Methods.

[6]  W. Richardson,et al.  Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination , 2004, Molecular and Cellular Neuroscience.

[7]  M. Raff,et al.  Long-Term Culture of Purified Postnatal Oligodendrocyte Precursor Cells , 2000, The Journal of cell biology.

[8]  D. Rowitch,et al.  CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. , 2010, Cell stem cell.

[9]  J. Chan,et al.  The geometric and spatial constraints of the microenvironment induce oligodendrocyte differentiation , 2008, Proceedings of the National Academy of Sciences.

[10]  R. Friede,et al.  Control of myelin formation by axon caliber. (With a model of the control mechanism) , 1972, The Journal of comparative neurology.

[11]  H. Keirstead,et al.  Identification of Post‐mitotic Oligodendrocytes Incapable of Remyelination within the Demyelinated Adult Spinal Cord , 1997, Journal of neuropathology and experimental neurology.

[12]  J. Voyvodic.  Target size regulates calibre and myelination of sympathetic axons , 1989, Nature.

[13]  Angeleen Fleming,et al.  Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects , 2010, Neuropharmacology.

[14]  D. Rowitch,et al.  Neurite outgrowth inhibitor Nogo-A establishes spatial segregation and extent of oligodendrocyte myelination , 2011, Proceedings of the National Academy of Sciences.

[15]  D. Rowitch,et al.  Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. , 2009, Genes & development.

[16]  Carmen Birchmeier,et al.  Axonal Neuregulin-1 Regulates Myelin Sheath Thickness , 2004, Science.

[17]  E. Shooter,et al.  NGF Controls Axonal Receptivity to Myelination by Schwann Cells or Oligodendrocytes , 2004, Neuron.

[18]  M. Noble,et al.  Cooperation between PDGF and FGF converts slowly dividing O-2Aadult progenitor cells to rapidly dividing cells with characteristics of O- 2Aperinatal progenitor cells , 1992, The Journal of cell biology.

[19]  V. Gallo,et al.  Adult-born SVZ progenitors receive transient glutamatergic synapses during remyelination of the corpus callosum , 2010, Nature Neuroscience.

[20]  J. Levine,et al.  Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord , 1998, Glia.

[21]  A. Bernardo,et al.  Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation, and differentiation , 2012, Developmental neurobiology.

[22]  Robin J. M. Franklin,et al.  Why does remyelination fail in multiple sclerosis? , 2002, Nature Reviews Neuroscience.

[23]  J. Chan,et al.  A rapid and reproducible assay for modeling myelination by oligodendrocytes using engineered nanofibers , 2013, Nature Protocols.

[24]  B. Barres,et al.  Purification and Characterization of Adult Oligodendrocyte Precursor Cells from the Rat Optic Nerve , 1998, The Journal of Neuroscience.

[25]  E. Huang,et al.  Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination , 2011, Nature Neuroscience.

[26]  B. Trapp,et al.  NG2-Positive Oligodendrocyte Progenitor Cells in Adult Human Brain and Multiple Sclerosis Lesions , 2000, The Journal of Neuroscience.

[27]  C. Heldin,et al.  Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. , 1998, Brain : a journal of neurology.